Melissa Heiry is a Neurology physician affiliated with Thomas Jefferson University. OpenAlex indexes 6 publications with 318 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
901 Walnut St Fl 4
Philadelphia, PA 191075214
Telephone
215-955-2724Registry record last updated 10 Sept 2019.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20255 payments
- PFIZER INC.Program year20254 payments
- ABBVIE INC.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.6%Aromatic Amino Acid Decarboxylation Inhibitor45%Carbidopa-Levodopa51%Carbidopa-Levodopa Er35%Rytary8%Carbidopa6%Part D≥152 patientsCholinesterase Inhibitor7.2%Rivastigmine65%Donepezil Hcl36%Part D<11 patients+ 15 more classes in this area
Cardiovascular
2.8%Beta blocker2.8%Propranolol Hcl100%Part D≥20 patientsMusculoskeletal
1.3%gamma-Aminobutyric Acid-ergic Agonist1.3%Baclofen100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prospective Connectomic‐Based Deep Brain Stimulation Programming for Parkinson's Disease
Movement Disorders
2024 - Improvement of GAD65-associated autoimmune epilepsy with testosterone replacement therapy
Neurology Neuroimmunology & Neuroinflammation
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”